VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,216,000 | +409.7% | 117,460 | +448.9% | 4.32% | +386.9% |
| Q3 2021 | $631,000 | -44.5% | 21,401 | -36.1% | 0.89% | -56.0% |
| Q2 2021 | $1,137,000 | +1.9% | 33,467 | -2.5% | 2.02% | +24.7% |
| Q1 2021 | $1,116,000 | -4.5% | 34,329 | -14.0% | 1.62% | +23.5% |
| Q4 2019 | $1,168,000 | +46.2% | 39,900 | +33.4% | 1.31% | +106.9% |
| Q3 2019 | $799,000 | -61.6% | 29,900 | -63.2% | 0.63% | -77.7% |
| Q2 2019 | $2,079,000 | -40.8% | 81,350 | -48.1% | 2.84% | +16.0% |
| Q1 2019 | $3,513,000 | +19.4% | 156,683 | +12.3% | 2.45% | -25.6% |
| Q4 2018 | $2,942,000 | -3.9% | 139,495 | -15.6% | 3.29% | +49.4% |
| Q3 2018 | $3,060,000 | +55.5% | 165,204 | +87.3% | 2.20% | +39.5% |
| Q2 2018 | $1,968,000 | -12.4% | 88,204 | -13.7% | 1.58% | -57.5% |
| Q1 2018 | $2,246,000 | +0.6% | 102,204 | +6.3% | 3.71% | +5.5% |
| Q4 2017 | $2,233,000 | – | 96,103 | – | 3.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |